Английская Википедия:Annexin Pharmaceuticals

Материал из Онлайн справочника
Версия от 08:58, 1 февраля 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Swedish pharmaceutical company}} {{Multiple issues| {{refimprove|date=February 2015}} {{Notability|Companies|date=October 2016}} }} '''Annexin Pharmaceuticals''' is a Swedish privately held biotech company<ref>{{cite journal|last1=Martz|first1=Lauren|title=Annexin: Attenuating vascular inflammation|journal=BioCentury|date=May 26, 2014|page=A18|url...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Multiple issues

Annexin Pharmaceuticals is a Swedish privately held biotech company[1][2] developing new therapeutic approaches for inflammatory cardiovascular diseases. The concept for the therapy is based on the anti-inflammatory properties of Annexin A5, a body own protective protein that acts simultaneously against several key pathogenic mechanisms of cardiovascular diseases. The company is currently focusing on treatment of peripheral artery disease (PAD).

References

Шаблон:Reflist

External links


Шаблон:Pharma-stub